Wyeth Nutrition today conducted a conference focused on “Nutrition and Early Infant Development”, as part of its efforts to promote infant and child health in the region. Some of the most eminent industry professionals, medical experts and scientists contributed their views on specific issues such as “Improving the Protein System of Infant Formulas” and “ Dietary Nucleotide Effects Upon Immune Function”
Conducted at the Grand Hyatt in Cairo, the main objective of the conference was to arrive at a common consensus on the crucial role of nutrition in the early stages of infancy leading to a healthy development, including raising awareness of the links between proper infant nutrition and healthy emotional, mental and physical development.
“Statistics on child mortality and illness in the Middle East tell an unsettling story of poor nutrition health among a significant number of infants and young children. This forum helped us discuss and address concerns in an integrated manner, thereby helping us evaluate the improvement parameters. The region certainly deserves better outcomes towards early infant development”, said Dr. Hussein Kamel Bahaa El-Din, former Minister of Education and Honorary President of Egyptian Society for Maternal and Neonatal Health.
“At Wyeth a healthy world is always our top priority. That’s why we believe in bringing together the best of medical experts, scientists and opinion leaders from all across the globe, to address global concerns and derive value added benefits from them, towards building a healthier nation. This conference was a platform for promoting good nutrition in the early infancy stages and continues our more than five decades helping ensure a nutritious start to life for children across the region.” said, Baher Massoud, Medical Director, Wyeth Nutrition
The conference witnessed the presence of 120 medical experts, nutritionists from across the Middle East, who actively contributed their feedback as part of an interactive session along with the present experts. Wyeth on its part conducts such forums on a regular basis to update medical fraternity across MENA to provide updates on subjects of crucial significance.
About Wyeth
Wyeth (NYSE:WYE) has leading products in the areas of women’s health care, cardiovascular disease, the central nervous system, inflammation, haemophilia, oncology, vaccines, and nutritional products. Wyeth is one of the world’s largest research-driven pharmaceutical and health care product companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.
